 RALEIGH, NC ACCESSWIRE May 5, 2020 9 Meters Biopharma NASDAQ:NMTR, a clinical-stage gastroenterology company focused on specialty, rare, and orphan diseases, today announced that it will host a research and development day webinar on its clinical pipeline of gastrointestinal therapies in short bowel syndrome and celiac disease on Wednesday, May 13, 2020 at 1 pm Eastern Time. The call will feature a presentation by Key Opinion Leaders KOLs Mark Pimentel, MD, FRCPC, from MAST Program, Cedars-Sinai, and Benjamin Lebwohl, MD, MS, from Columbia University Medical Center, who will discuss the unmet medical needs in treating patients with short bowel syndrome SBS and celiac disease CeD, current standards of care and the 9 Meters approach. 